Research & Literature

Pathophysiology of Liver Fibrosis.

Pinzani M

Digestive diseases (Basel, Switzerland) 2015; (33(4)):492-7 doi:10.1159/000374096.

Clinical Evaluation and Prognosis.

Hernández-Gea V, Berzigotti A

Digestive diseases (Basel, Switzerland) 2015; (33(4)):515-23 doi:10.1159/000374100.

Renal Function and Transplantation in Liver Disease.

Parajuli S, Foley D, Djamali A, Mandelbrot D

Transplantation 2015; (99(9)):1756-64 doi:10.1097/TP.0000000000000820.

Role of EUS evaluation after endoscopic eradication of esophageal varices with band ligation.

Carneiro FO, Retes FA, Matuguma SE, et al.

Gastrointestinal endoscopy 2016; (84(3)):400-7.

Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?

D'Ambrosio R, Colombo M

Liver international : official journal of the International Association for the Study of the Liver 2016; (36(6)):783-90 doi:10.1111/liv.13106.

Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.

Barboza KC, Salinas LM, Sahebjam F, et al.

Metabolic brain disease 2016; (31(4)):869-80 doi:10.1007/s11011-016-9817-y.

Angiogenesis and portal-systemic collaterals in portal hypertension.

Gana JC, Serrano CA, Ling SC

Annals of hepatology 2016; (15(3)):303-13 doi:10.5604/16652681.1198799.

Kidney Injury in Liver Disease.

Regner KR, Singbartl K

Critical care clinics 2016; (32(3)):343-55.

Reversal of liver cirrhosis: current evidence and expectations.

Jung YK, Yim HJ

The Korean journal of internal medicine 2017; (32(2)):213-228 doi:10.3904/kjim.2016.268.

Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.

Atiemo K, Skaro A, Maddur H, et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017; (17(9)):2410-2419 doi:10.1111/ajt.14239.

Hepatic encephalopathy.

Ferenci P

Gastroenterology report 2017; (5(2)):138-147 doi:10.1093/gastro/gox013.

Practical Issues in the Management of Overt Hepatic Encephalopathy.

Pantham G, Mullen KD

Gastroenterology & hepatology 2017; (13(11)):659-665.

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

Tzartzeva K, Obi J, Rich NE, et al.

Gastroenterology 2018; (154(6)):1706-1718.e1 doi:10.1053/j.gastro.2018.01.064.

The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.

Meersseman P, Langouche L, du Plessis J, et al.

Journal of hepatology 2018; (69(4)):803-809 doi:10.1016/j.jhep.2018.04.025.

Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.

Aby E, Phan J, Truong E, et al.

Journal of clinical gastroenterology 2019; (53(2)):142-146 doi:10.1097/MCG.0000000000001075.

Refractory Ascites in Liver Cirrhosis.

Adebayo D, Neong SF, Wong F

The American journal of gastroenterology 2019; (114(1)):40-47 doi:10.1038/s41395-018-0185-6.

Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.

Nagai S, Chau LC, Schilke RE, et al.

Gastroenterology 2018; (155(5)):1451-1462.e3 doi:10.1053/j.gastro.2018.07.025.

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.

Abraldes JG, Trebicka J, Chalasani N, et al.

Hepatology (Baltimore, Md.) 2019; (69(3)):1287-1299 doi:10.1002/hep.30314.

Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.

Nevens F, Bittencourt PL, Coenraad MJ, et al.

Digestive diseases and sciences 2019; (64(6)):1419-1431 doi:10.1007/s10620-018-5448-y.

Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles.

Weissenborn K

Drugs 2019; (79(Suppl 1)):5-9 doi:10.1007/s40265-018-1018-z.

Bone Health in Patients With Liver Diseases.

Danford CJ, Trivedi HD, Bonder A

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2020; (23(2)):212-222 doi:10.1016/j.jocd.2019.01.004.

Bone microarchitecture and bone turnover in hepatic cirrhosis.

Wakolbinger R, Muschitz C, Scheriau G, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1195-1204 doi:10.1007/s00198-019-04870-6.

Understanding the impact of neurologic complications in patients with cirrhosis.

Allampati SK, Mullen KD

SAGE open medicine 2019; (7()):2050312119832090 doi:10.1177/2050312119832090.

Liver Allocation Policies in the USA: Past, Present, and the Future.

Pillai A, Couri T, Charlton M

Digestive diseases and sciences 2019; (64(4)):985-992 doi:10.1007/s10620-019-05549-y.

A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree?

Theodoridis X, Grammatikopoulou MG, Petalidou A, et al.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2020; (35(1)):98-107 doi:10.1002/ncp.10393.

Nutritional support in cirrhotic patients with sarcopenia.

Vasques J, Guerreiro CS, Sousa J, et al.

Clinical nutrition ESPEN 2019; (33()):12-17 doi:10.1016/j.clnesp.2019.07.011.

[Nutrition in Liver Cirrhosis: Clinical Practice Recommendations].

Plauth M

Deutsche medizinische Wochenschrift (1946) 2019; (144(18)):1267-1274 doi:10.1055/a-0753-6081.

Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.

Weersink RA, Burger DM, Hayward KL, et al.

Expert opinion on drug metabolism & toxicology 2020; (16(1)):45-57 doi:10.1080/17425255.2020.1702022.

Quantifying Sex-Based Disparities in Liver Allocation.

Locke JE, Shelton BA, Olthoff KM, et al.

JAMA surgery 2020; (155(7)):e201129 doi:10.1001/jamasurg.2020.1129.

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.

Bohra A, Worland T, Hui S, et al.

World journal of gastroenterology 2020; (26(18)):2221-2231 doi:10.3748/wjg.v26.i18.2221.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

Lens S, Baiges A, Alvarado-Tapias E, et al.

Journal of hepatology 2020; (73(6)):1415-1424 doi:10.1016/j.jhep.2020.05.050.

Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review.

Mandorfer M, Hernández-Gea V, García-Pagán JC, Reiberger T

Seminars in liver disease 2020; (40(3)):240-255 doi:10.1055/s-0040-1708806.

Where does TIPS fit in the management of patients with cirrhosis?

García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G

JHEP reports : innovation in hepatology 2020; (2(4)):100122 doi:10.1016/j.jhepr.2020.100122.

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Sumida Y, Yoneda M, Seko Y, et al.

Diagnostics (Basel, Switzerland) 2020; (10(8)) doi:10.3390/diagnostics10080579.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Nicoară-Farcău O, Han G, Rudler M, et al.

Gastroenterology 2021; (160(1)):193-205.e10 doi:10.1053/j.gastro.2020.09.026.

Guidelines on the management of ascites in cirrhosis.

Aithal GP, Palaniyappan N, China L, et al.

Gut 2021; (70(1)):9-29 doi:10.1136/gutjnl-2020-321790.

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.

Schoenberger H, Chong N, Fetzer DT, et al.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(7)):1561-1569.e4 doi:10.1016/j.cgh.2021.06.012.

Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.

Nilles KM, Levitsky J

Seminars in liver disease 2021; (41(3)):308-320 doi:10.1055/s-0041-1729969.

Towards a new definition of decompensated cirrhosis.

D'Amico G, Bernardi M, Angeli P

Journal of hepatology 2022; (76(1)):202-207 doi:10.1016/j.jhep.2021.06.018.

Spontaneous bacterial peritonitis: update on diagnosis and treatment.

Popoiag RE, Fierbințeanu-Braticevici C

Romanian journal of internal medicine = Revue roumaine de medecine interne 2021; (59(4)):345-350 doi:10.2478/rjim-2021-0024.

Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review.

Pimentel R, Gregório C, Figueiredo P

Acta gastro-enterologica Belgica 2021; (84(2)):333-342 doi:10.51821/84.2.333.

Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.

Khan S, Saxena R

Advances in anatomic pathology 2021; (28(6)):408-414 doi:10.1097/PAP.0000000000000312.

Non-invasive diagnosis and follow-up of portal hypertension.

Thabut D, Weil D, Bouzbib C, et al.

Clinics and research in hepatology and gastroenterology 2022; (46(8)):101767 doi:10.1016/j.clinre.2021.101767.

MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.

Kim WR, Mannalithara A, Heimbach JK, et al.

Gastroenterology 2021; (161(6)):1887-1895.e4 doi:10.1053/j.gastro.2021.08.050.

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.

Sanyal AJ, Anstee QM, Trauner M, et al.

Hepatology (Baltimore, Md.) 2022; (75(5)):1235-1246 doi:10.1002/hep.32204.

Vaccination in Chronic Liver Disease: An Update.

Alukal JJ, Naqvi HA, Thuluvath PJ

Journal of clinical and experimental hepatology 2022; (12(3)):937-947 doi:10.1016/j.jceh.2021.12.003.

Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies.

de Mattos ÂZ, Terra C, Farias AQ, et al.

World journal of gastrointestinal endoscopy 2021; (13(12)):628-637 doi:10.4253/wjge.v13.i12.628.

Liver transplant allocation policies and outcomes in United States: A comprehensive review.

Latt NL, Niazi M, Pyrsopoulos NT

World journal of methodology 2022; (12(1)):32-42 doi:10.5662/wjm.v12.i1.32.

Baveno VII - Renewing consensus in portal hypertension.

de Franchis R, Bosch J, Garcia-Tsao G, et al.

Journal of hepatology 2022; (76(4)):959-974 doi:10.1016/j.jhep.2021.12.022.

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis.

Nagel M, Weidner V, Schulz S, et al.

Health and quality of life outcomes 2022; (20(1)):23 doi:10.1186/s12955-022-01923-z.

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.

Carol M, Pérez-Guasch M, Solà E, et al.

PloS one 2022; (17(4)):e0265153 doi:10.1371/journal.pone.0265153.

Anxiety in cirrhosis: a prospective study on prevalence and development of a practical screening nomogram.

Dang TT, Patel K, Farhat K, et al.

European journal of gastroenterology & hepatology 2022; (34(5)):553-559 doi:10.1097/MEG.0000000000002301.

Update on the Evaluation and Management of Portal Hypertension.

Aitcheson G, Cezar C, John I, John BV

Gastroenterology & hepatology 2021; (17(12)):569-578.

Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.

Baiges A, Hernández-Gea V

Clinical drug investigation 2022; (42(Suppl 1)):25-31 doi:10.1007/s40261-022-01147-5.

Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.

Bai W, Abraldes JG

Current opinion in gastroenterology 2022; (38(3)):206-215 doi:10.1097/MOG.0000000000000824.

Management of refractory ascites.

Wong F

Clinical and molecular hepatology 2023; (29(1)):16-32 doi:10.3350/cmh.2022.0104.

Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.

Singal AG, Haaland B, Parikh ND, et al.

Hepatology communications 2022; (6(10)):2925-2936 doi:10.1002/hep4.2045.

Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

Gralnek IM, Camus Duboc M, Garcia-Pagan JC, et al.

Endoscopy 2022; (54(11)):1094-1120 doi:10.1055/a-1939-4887.

Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.

Zheng X, Bai Z, Wang T, et al.

Advances in therapy 2023; (40(4)):1494-1529 doi:10.1007/s12325-023-02430-3.

Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients.

Beran A, Mhanna A, Mhanna M, et al.

Proceedings (Baylor University. Medical Center) 2023; (36(2)):151-156 doi:10.1080/08998280.2023.2165344.

Diagnosis and Management of Esophagogastric Varices.

Pallio S, Melita G, Shahini E, et al.

Diagnostics (Basel, Switzerland) 2023; (13(6)) doi:10.3390/diagnostics13061031.

Diagnosis and Management of Cirrhosis and Its Complications: A Review.

Tapper EB, Parikh ND

JAMA 2023; (329(18)):1589-1602 doi:10.1001/jama.2023.5997.

Emergency medicine updates: Spontaneous bacterial peritonitis.

Long B, Gottlieb M

The American journal of emergency medicine 2023; (70()):84-89 doi:10.1016/j.ajem.2023.05.015.

A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, et al.

Journal of hepatology 2023; (79(6)):1542-1556 doi:10.1016/j.jhep.2023.06.003.

Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.

Dajti E, Ravaioli F, Zykus R, et al.

The lancet. Gastroenterology & hepatology 2023; (8(9)):816-828 doi:10.1016/S2468-1253(23)00150-4.

MELD 3.0 in Advanced Chronic Liver Disease.

Mazumder NR, Fontana RJ

Annual review of medicine 2024; (75()):233-245 doi:10.1146/annurev-med-051322-122539.

Natural history of metabolic dysfunction-associated steatotic liver disease.

Lekakis V, Papatheodoridis GV

European journal of internal medicine 2024; (122()):3-10 doi:10.1016/j.ejim.2023.11.005.

THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION.

Mattos AA, Mattos AZ, Sartori GDP, et al.

Arquivos de gastroenterologia 2023; (60(4)):525-535 doi:10.1590/S0004-2803.230402023-64.

Cross-sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease.

Medina SP, Kim RG, Magee C, et al.

Obesity science & practice 2023; (9(6)):581-589 doi:10.1002/osp4.688.

Perceived Stigma in Patients with Autoimmune Hepatitis.

Naftaly JP, Feldman ECH, Greenley RN

Journal of clinical psychology in medical settings 2024; (31(2)):455-464 doi:10.1007/s10880-023-09983-z.

Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials.

Kawaguchi T, Kawaguchi A, Hashida R, et al.

Journal of gastroenterology 2024; (59(3)):216-228 doi:10.1007/s00535-023-02060-0.

Acute and non-acute decompensation of liver cirrhosis.

McCoy MS, Angeli P, Trebicka J

Liver international : official journal of the International Association for the Study of the Liver 2025; (45(3)):e15861 doi:10.1111/liv.15861.

The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis.

Iannone G, Pompili E, De Venuto C, et al.

Journal of clinical medicine 2024; (13(5)) doi:10.3390/jcm13051349.

Novel approaches in the medical management of compensated cirrhosis.

Moreno-Loro A, Giráldez Á, Jiménez F, et al.

Expert review of gastroenterology & hepatology 2024; (18(6)):239-256 doi:10.1080/17474124.2024.2358149.

Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications.

Flamm SL

The American journal of medicine 2024; (137(10)):929-938 doi:10.1016/j.amjmed.2024.05.015.

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

, ,

Journal of hepatology 2024; (81(3)):492-542 doi:10.1016/j.jhep.2024.04.031.

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

, ,

Obesity facts 2024; (17(4)):374-444 doi:10.1159/000539371.

Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression.

Mendoza YP, Tsouka S, Semmler G, et al.

Journal of hepatology 2024; (81(6)):983-994 doi:10.1016/j.jhep.2024.06.028.

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.

Younossi ZM, AlQahtani SA, Funuyet-Salas J, et al.

JHEP reports : innovation in hepatology 2024; (6(7)):101066 doi:10.1016/j.jhepr.2024.101066.

Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.

Wasserman RD, Abel W, Monkemuller K, et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (35(8)):599-608 doi:10.5152/tjg.2024.23507.

A Clinical Review of Noninvasive Tests for Hepatic Fibrosis.

Chadha N, Sterling RK

Gastroenterology & hepatology 2024; (20(6)):322-329.

Mechanisms coupling lipid droplets to MASLD pathophysiology.

Reid MV, Fredickson G, Mashek DG

Hepatology (Baltimore, Md.) 2026; (84(1)):273-291 doi:10.1097/HEP.0000000000001141.

Update on Hepatorenal Syndrome: From Pathophysiology to Treatment.

Khemichian S, Nadim MK, Terrault NA

Annual review of medicine 2025; (76(1)):373-387 doi:10.1146/annurev-med-050223-112947.

TIPS and hepatic encephalopathy in patients with cirrhosis.

Bozon-Rivière P, Rudler M, Weiss N, Thabut D

Metabolic brain disease 2025; (40(2)):117 doi:10.1007/s11011-025-01541-w.

A novel risk-predicted nomogram for acute kidney injury progression in decompensated cirrhosis: a double-center study in Vietnam.

Nguyen NN, Nguyen BT, Nguyen TDT, et al.

International urology and nephrology 2025; (57(7)):2279-2290 doi:10.1007/s11255-025-04398-1.

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.

Li Y, Zhu B, Shi K, et al.

Frontiers in medicine 2025; (12()):1515400 doi:10.3389/fmed.2025.1515400.

Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis.

Shirinezhad A, Eshlaghi FM, Salabat D, et al.

BMC gastroenterology 2025; (25(1)):115 doi:10.1186/s12876-025-03720-6.

Decompensated cirrhosis but low MELD-Should we wait or refer for liver transplantation?

Singh N, Wong YJ, Burra P, et al.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2025; (31(11)):1423-1432 doi:10.1097/LVT.0000000000000608.

Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives.

Brown RS, Brown KA, Flamm S, et al.

Hepatology communications 2025; (9(4)) doi:10.1097/HC9.0000000000000682.

ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.

Singal AK, Wong RJ, Dasarathy S, et al.

The American journal of gastroenterology 2025; (120(5)):950-972 doi:10.14309/ajg.0000000000003379.

Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis.

Balcar L, Fromme M, Kappe N, et al.

JHEP reports : innovation in hepatology 2025; (7(6)):101398 doi:10.1016/j.jhepr.2025.101398.

The unwell patient with advanced chronic liver disease: when to use each score?

Moore O, Ma WS, Read S, et al.

BMC medicine 2025; (23(1)):413 doi:10.1186/s12916-025-04185-w.

Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases.

Lytvyak E, Hirschfield G, Shreekumar D, et al.

Liver international : official journal of the International Association for the Study of the Liver 2025; (45(8)):e70190 doi:10.1111/liv.70190.

Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

Tomassoni DR, Schildkraut T, Ramachandran V, et al.

World journal of gastroenterology 2025; (31(27)):107740 doi:10.3748/wjg.v31.i27.107740.

Hepatic Hydrothorax: A Review.

Ismail A, Awadalla M, Pothuraju S, Singal AK

Current hepatology reports 2025; (24(1)) doi:10.1007/s11901-025-00677-8.

Exercise and nutrition interventions for sarcopenia in cirrhosis: a systematic review and network meta-analysis of randomized controlled trials.

Kittiprachakul S, Maung ST, Poorirerngpoom N, et al.

European journal of clinical nutrition 2025; (79(11)):1087-1098 doi:10.1038/s41430-025-01642-w.

Sepsis Drives Severity and Mortality in Acute-on-Chronic Liver Failure Among ICU Patients with Alcohol-Related Cirrhosis: A Retrospective Single-Center Study.

von Maldeghem E, Zimmermann K, Mester P, et al.

Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14197025.

[Hepatic encephalopathy in liver cirrhosis].

Labenz C

Deutsche medizinische Wochenschrift (1946) 2026; (151(4)):149-155 doi:10.1055/a-2647-5748.

[Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome - Complications of circulatory failure in cirrhosis].

Zipprich A, Ripoll C

Deutsche medizinische Wochenschrift (1946) 2026; (151(4)):163-170 doi:10.1055/a-2647-5845.

New insight on hepatic encephalopathy: a comprehensive review.

Sedik AA, Alrefaei R

Journal of basic and clinical physiology and pharmacology 2026; (37(4)):293-303 doi:10.1515/jbcpp-2025-0166.

Assessing alcohol consumption in an era of direct alcohol markers.

Jönsson C, Ekstedt M, Nasr P

JHEP reports : innovation in hepatology 2026; (8(9)):101906 doi:10.1016/j.jhepr.2026.101906.

Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative Review.

Pyrsopoulos NT, Gunn N, Jalal PK, Catinis GE

Journal of clinical and translational hepatology 2026; (14(6)):674-686 doi:10.14218/JCTH.2025.00698.

Limitations of MELD in Isolated Polycystic Liver Disease: Fatal Traumatic Cyst Rupture Complicated by Abdominal Compartment Syndrome.

Vinton ZC, Schulz CA, Melquist SJ, Kulig CC

Case reports in hepatology 2026; (2026()):5849774 doi:10.1155/crhe/5849774.